AKT1 and cancer: By blocking the PI3 K/Akt/mTOR axis and reducing cancer stem cell indicators such as ALDH, piperine and doxorubicin in combination helps to overcome chemoresistance in triple-negative breast cancer (TNBC) (Hakeem et al. 2024).